Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,973
Award facts
- Contract value 100% obligated
- $97,972.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,972.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to the Department of Defense, including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals spanning oncology treatments, immunosuppressants, emergency medications, and routine drugs.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a $499.9 million ceiling value and extends through December 31, 2036, comprising a 30-month base period with three 30-month option periods. This contract positions DMS Pharmaceutical Group as a critical pharmaceutical supplier enabling the Department of Defense to fulfill diverse and specialized pharmaceutical requirements across its global military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMMP?
SPE2DU26FEMMP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DU26FEMMP worth?
The government has obligated $97,973 on SPE2DU26FEMMP.
Is contract SPE2DU26FEMMP an order under another contract?
Yes. SPE2DU26FEMMP is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMP competed?
The extent of competition for SPE2DU26FEMMP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award